- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 135086, 13 pages
A Pipeline with Multiplex Reverse Transcription Polymerase Chain Reaction and Microarray for Screening of Chromosomal Translocations in Leukemia
1School of Life Science and Technology, Tongji University, Shanghai 200092, China
2National Engineering Research Center for Biochip at Shanghai, Shanghai 201203, China
3Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China
4State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
5Wayen Biotechnologies Inc., Shanghai 201203, China
Received 21 May 2013; Revised 1 August 2013; Accepted 19 August 2013
Academic Editor: Luca Arcaini
Copyright © 2013 Fei-Fei Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. W. Vardiman, N. L. Harris, and R. D. Brunning, “The World Health Organization (WHO) classification of the myeloid neoplasms,” Blood, vol. 100, no. 7, pp. 2292–2302, 2002.
- J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009.
- A. T. Look, “Oncogenic transcription factors in the human acute leukemias,” Science, vol. 278, no. 5340, pp. 1059–1064, 1997.
- J. Gabert, E. Beillard, V. H. J. van der Velden et al., “Standardization and quality control studies of 'real time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—a Europe Against Cancer Program,” Leukemia, vol. 17, no. 12, pp. 2318–2357, 2003.
- P. Raanani and I. Ben-Bassat, “Detection of minimal residual disease in acute myelogenous leukemia,” Acta Haematologica, vol. 112, no. 1-2, pp. 40–54, 2004.
- C.-H. Pui, M. V. Relling, and J. R. Downing, “Mechanisms of disease: acute lymphoblastic leukemia,” The New England Journal of Medicine, vol. 350, no. 15, pp. 1535–1548, 2004.
- N. Pallisgaard, P. Hokland, D. C. Riishøj, B. Pedersen, and P. Jørgensen, “Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia,” Blood, vol. 92, no. 2, pp. 574–588, 1998.
- M. Salto-Tellez, S. G. Shelat, B. Benoit et al., “Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice,” Journal of Molecular Diagnostics, vol. 5, no. 4, pp. 231–236, 2003.
- R. L. King, M. Naghashpour, C. D. Watt, J. J. D. Morrissette, and A. Bagg, “A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics,” American Journal of Clinical Pathology, vol. 135, no. 6, pp. 921–928, 2011.
- J. Wallace, Y. Zhou, G. N. Usmani et al., “BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays,” Leukemia, vol. 17, no. 7, pp. 1411–1413, 2003.
- T. Nasedkina, P. Domer, V. Zharinov, J. Hoberg, Y. Lysov, and A. Mirzabekov, “Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays,” Haematologica, vol. 87, no. 4, pp. 363–372, 2002.
- T. V. Nasedkina, V. S. Zharinov, E. A. Isaeva et al., “Clinical Screening of Gene Rearrangements in Childhood Leukemia by Using a Multiplex Polymerase Chain Reaction-Microarray Approach,” Clinical Cancer Research, vol. 9, no. 15, pp. 5620–5629, 2003.
- N. Maroc, A. Morel, E. Beillard et al., “A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia,” Leukemia, vol. 18, no. 9, pp. 1522–1530, 2004.
- S. Giusiano, C. Formisano-Treziny, A. Benziane et al., “Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis,” International Journal of Laboratory Hematology, vol. 32, no. 4, pp. 398–409, 2010.
- E. Beillard, N. Pallisgaard, V. H. J. van der Velden et al., “Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)—a Europe against cancer program,” Leukemia, vol. 17, no. 12, pp. 2474–2486, 2003.
- C.-H. Pui, L. L. Robison, and A. T. Look, “Acute lymphoblastic leukaemia,” The Lancet, vol. 371, no. 9617, pp. 1030–1043, 2008.
- M. Aricò, M. G. Valsecchi, B. Camitta et al., “Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia,” The New England Journal of Medicine, vol. 342, no. 14, pp. 998–1006, 2000.
- D. Grimwade and R. K. Hills, “Independent prognostic factors for AML outcome,” Hematology, pp. 385–395, 2009.
- S. E. Aspland, H. H. Bendall, and C. Murre, “The role of E2A-PBX1 in leukemogenesis,” Oncogene, vol. 20, no. 40, pp. 5708–5717, 2001.
- C.-H. Pui, J. M. Boyett, G. K. Rivera et al., “Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude children's research hospital,” Leukemia, vol. 14, no. 12, pp. 2286–2294, 2000.
- M. Schrappe, M. Aricò, J. Harbott et al., “Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome,” Blood, vol. 92, no. 8, pp. 2730–2741, 1998.
- C.-H. Pui, P. S. Gaynon, J. M. Boyett et al., “Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region,” The Lancet, vol. 359, no. 9321, pp. 1909–1915, 2002.
- J. B. Nachman, N. A. Heerema, H. Sather et al., “Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia,” Blood, vol. 110, no. 4, pp. 1112–1115, 2007.
- J. E. Rubnitz, S. C. Raimondi, X. Tong et al., “Favorable impact of the t(9;11) in childhood acute myeloid leukemia,” Journal of Clinical Oncology, vol. 20, no. 9, pp. 2302–2309, 2002.
- R. Z. Shi, J. M. Morrissey, and J. D. Rowley, “Screening and quantification of multiple chromosome translocations in human leukemia,” Clinical Chemistry, vol. 49, no. 7, pp. 1066–1073, 2003.